Generation of AAV Using Chemically-Defined Media

To view the webinar, please login to your account.

No account yet? Register.

TheraPEAK™ SfAAV™ Medium – the next step in AAV production

Learn how the TheraPEAK™ SfAAV™ Medium can enhance your AAV production and aid you in bringing safe and life-saving gene therapies to patients faster.

Watch this 15-minute webinar and learn how Lonza's new TheraPEAK^TM SfAAV^TM Medium can help to streamline and accelerate the production of AAV in Sf9 cells.

The data presented by Senior Scientist Jerome Jacques shows how this new chemically-defined medium allows for increased AAV production, consistent cell growth and reduced downstream purification, streamlining process scale-up for the commercialization of gene therapies.

Topics discussed

Features and benefits of using TheraPEAK^TM SfAAV^TM Medium for gene therapy applications
Performance comparison against other off-the-shelf media
Production of different serotypes of AAV using TheraPEAK^TM SfAAV^TM Medium

Are you interested to learn more about the medium and its performance?
Would you like to test it?

Contact us

Interested in our Webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars.

View topics

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Subscribe now

Do you need a quote or any support?

Contact us and one of our local representatives will get back to you shortly to discuss your needs or any pricing questions.

Request info or quote

Streamlined Generation of AAV Using Chemically-Defined Media

TheraPEAK™ SfAAV™ Medium – the next step in AAV production

Interested in our Webinars?

Subscribe to our eNewsletter

Do you need a quote or any support?